Risk factors in the development of stem cell therapy
Carla Herberts(Medicines Evaluation Board), Harm PH Hermsen(National Institute for Public Health and the Environment)
Cited by 760
Related Papers
The Evolution of Nonclinical Regulatory Science: Advanced Therapy Medicinal Products as a Paradigm
|Molecular Therapy|2013|24